See also this year's filing and all EDGAR filings for this company.
PDF Report 0001563463_2021_Nutralife_Biosciences_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | No stock price available | subcommand.plot | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001563463')"} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001563463')"} |
Graph
Absolute values for 0001563463, Nutralife Biosciences INC
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 1,251,259 |
| 1 | AssetsCurrent | 722,462 |
| 2 | PropertyPlantAndEquipment | 2,314,661 |
| 3 | remainder_Assets | 418,326 |
| 4 | LiabilitiesLongTerm | 497,593 |
| 5 | LiabilitiesCurrent | 3,784,118 |
| 6 | remainder_Liabilities | 123,887 |
| 7 | GeneralAndAdministrativeExpense | 1,804,765 |
| 8 | SellingAndMarketingExpense | 176,430 |
| 9 | remainder_Expenses | 1,247,641 |
| 10 | remainder_Revenues | 1,255,784 |
| 11 | remainder_NetIncome | -916,888 |
| 12 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 4,706,708 |
| 1 | Liabilities | 4,405,598 |
| 2 | Expenses | 3,228,836 |
| 3 | Revenues | 1,255,784 |
| 4 | StockholdersEquity | 301,110 |
| 5 | NetIncome | -2,889,940 |
| 6 | ComprehensiveNetIncome | -2,889,940 |
| 7 | BaseVar | 7,256,907 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.601 |
| 9 | EconomicCapitalRatio | 1.24 |
Edgar->Model Mapping
Feature Distribution
Change over Time
